The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder.
about
N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of actionOsteoprotegerin levels in patients with severe mental disordersCelecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On TrialsA Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical CorrelatesThe neuroimmunology of schizophreniaThe Potential Role of the NLRP3 Inflammasome as a Link between Mitochondrial Complex I Dysfunction and Inflammation in Bipolar DisorderBiomarkers in schizophrenia: A focus on blood based diagnostics and theranosticsAutoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feelingPriming of metabolic dysfunctions by prenatal immune activation in mice: relevance to schizophrenia.The relationship between interleukin-1 receptor antagonist and cognitive function in older adults with bipolar disorder.Experimental human endotoxemia enhances brain activity during social cognition.Identification of subgroups of schizophrenia patients with changes in either immune or growth factor and hormonal pathwaysAntigliadin Antibodies (AGA IgG) Are Related to Neurochemistry in Schizophrenia.Autism and increased paternal age related changes in global levels of gene expression regulation.Increased M1/decreased M2 signature and signs of Th1/Th2 shift in chronic patients with bipolar disorder, but not in those with schizophrenia.Dose-dependent effects of endotoxin on neurobehavioral functions in humansIntracellular monocytic cytokine levels in schizophrenia show an alteration of IL-6.Translating progress in depression research to the clinic: one step at a time on a very long roadEffectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review.A critical review of pro-cognitive drug targets in psychosis: convergence on myelination and inflammation.IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophrenia.Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?Altered activation of innate immunity associates with white matter volume and diffusion in first-episode psychosis.Prenatal maternal immune disruption and sex-dependent risk for psychoses.Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2x2 clinical trialMorphological features of microglial cells in the hippocampal dentate gyrus of Gunn rat: a possible schizophrenia animal modelDifferential expression of the inflammation marker IL12p40 in the at-risk mental state for psychosis: a predictor of transition to psychotic disorder?Cerebrospinal fluid metabolome in mood disorders-remission state has a unique metabolic profileAssociations between comorbid anxiety, diabetes control, and overall medical burden in patients with serious mental illness and diabetes.Inflammation and neurological disease-related genes are differentially expressed in depressed patients with mood disorders and correlate with morphometric and functional imaging abnormalities.Abnormal gene expression of proinflammatory cytokines and their membrane-bound receptors in the lymphocytes of depressed patientsDoes Systemic Inflammation Play a Role in Pediatric Psychosis?Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia.Proinflammatory cytokines and their membrane-bound receptors are altered in the lymphocytes of schizophrenia patients.Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects.Immune system disturbances in schizophrenia.The 3rd Schizophrenia International Research Society Conference, 14-18 April 2012, Florence, Italy: summaries of oral sessions.Glia and immune cell signaling in bipolar disorder: insights from neuropharmacology and molecular imaging to clinical application.Sleep and inflammatory markers in different psychiatric disorders.Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder.
P2860
Q24615952-459DB98C-C046-4016-B6CB-FBA76947F86CQ24626094-6CB0D29D-2091-445C-91D6-DCEB2306D113Q26741541-3A100DFF-1D9C-4A51-B2C9-FDFC2F1F7318Q26786354-AC3D25AB-1D46-4EAF-BAA3-1D2537023566Q26859392-9701843E-B4CB-440F-B411-463D1D412E97Q26862278-0E100D30-7A27-4AAA-8515-8598DDB11720Q28068871-4F3FA20D-079A-4E0F-8388-AA39A81293C7Q28244133-4EDCE76A-253C-41AD-93EA-C7603E9EB4AFQ30442468-3A106A09-5510-4C5F-A70B-B496C7290AFBQ33578766-A00B0C43-9A64-4557-BDFE-B5A3A59D7AD8Q33692251-5D8F8641-5524-422C-9C7B-D32A05C761C9Q33762512-1EA30446-2DF3-4475-AC63-B4E6B5ED0A24Q33809544-D2B3BFDB-C8F0-4EC0-9A66-4911C93B9B1CQ33838419-6CB5C16B-8D4E-4ADB-A61E-D63FCA595323Q33990603-D6EAFB2C-6A16-4847-A523-DC3C976DBBD5Q34099178-A6D05319-1007-4F00-B78E-B4C9D46FA521Q34136922-3B7EC16B-71AE-4D27-82DF-198669F99FE9Q34169092-2EF27553-8A3F-4FF3-B275-AF5783A8D31CQ34384181-58891B05-F8A7-45E0-9CE0-4D29E982C351Q34405264-67F3FD15-693E-46B6-A62A-B605B874EA94Q34764938-A2CB479B-9A07-4429-B8E7-D0FFFA53A670Q35225947-A0446256-00F1-460C-AA4F-5DEDF9EE0D1DQ35603078-B63A9C54-A907-4983-96DF-7B4A0E0BC230Q35770280-62557098-2A7C-4A75-BBD6-247FF7AD1113Q35789318-AF685EB0-0158-40C3-AF40-2C3DBE319295Q35907956-14B7791A-A4BE-46ED-BB70-3317FA31B87FQ36138754-3CD7F117-5715-471A-A9E6-3BE20D2A821FQ36246448-62D99CA6-307E-4B21-AB13-0294D949E5D3Q36424084-64D4ACEB-84D5-4CAB-8B5E-1D12C18BE59BQ36625412-47B5390C-F3B6-4F5B-8750-D0E35A5001C6Q36948381-E6CAE60C-E5B7-4E58-AF15-A81152193D90Q36986370-9D143C70-35D4-49F9-B184-7895794A1368Q37067281-D2D7D1F2-03F5-4196-97EF-A4D204DDC893Q37083097-5494AF2F-836A-4121-9071-FC9399D641D7Q37275549-6FAACD70-D018-4864-A3B3-D538CFE49BF1Q37344544-62C140F0-9E59-491C-A950-E50D095B6669Q37425054-868544B0-8692-4249-8933-C31EE0B4EE78Q37526428-9CD3F4A6-44CD-4E81-9C4B-90C99447CBC1Q37614680-99A81F1B-4A9E-4E9B-8869-BB8E06969B0DQ37621319-F2387BC6-69C1-495D-9CBE-FE8EF39BF25E
P2860
The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The mononuclear phagocyte syst ...... ophrenia and bipolar disorder.
@ast
The mononuclear phagocyte syst ...... ophrenia and bipolar disorder.
@en
The mononuclear phagocyte syst ...... ophrenia and bipolar disorder.
@nl
type
label
The mononuclear phagocyte syst ...... ophrenia and bipolar disorder.
@ast
The mononuclear phagocyte syst ...... ophrenia and bipolar disorder.
@en
The mononuclear phagocyte syst ...... ophrenia and bipolar disorder.
@nl
prefLabel
The mononuclear phagocyte syst ...... ophrenia and bipolar disorder.
@ast
The mononuclear phagocyte syst ...... ophrenia and bipolar disorder.
@en
The mononuclear phagocyte syst ...... ophrenia and bipolar disorder.
@nl
P2093
P2860
P356
P1476
The mononuclear phagocyte syst ...... ophrenia and bipolar disorder.
@en
P2093
Esther M Knijff
Hemmo A Drexhage
Leonie van der Heul-Nieuwenhuijzen
Marjan A Versnel
Roos C Padmos
Roosmarijn C Drexhage
Wouter Beumer
P2860
P356
10.1586/ERN.09.144
P577
2010-01-01T00:00:00Z